ArriVent BioPharma Reports Second Quarter 2026 Financial Results
Go back to ArriVent BioPharma Reports Second Quarter 2026 Financial Results| (NASDAQ: AVBP) | Delayed: 29.18 -0.84 (2.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.02 | 52 Week High | $ | |||
| Open | $29.73 | 52 Week Low | $ | |||
| Day High | $29.81 | P/E | N/A | |||
| Day Low | $28.64 | EPS | $ | |||
| Volume | 406,273 | |||||

